Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Tianli Weikang Pharmaceutical Technology appears to be a China-based pharmaceutical technology and chemical manufacturing company focused on pharmaceutical intermediates rather than a clinical-stage biotech pipeline. Publicly available references point to an investment project for annual production of pharmaceutical intermediates, including albendazole-related manufacturing capacity. The company therefore looks more like an industrial pharmaceutical supply or API/intermediate producer than a therapeutics developer. There is no clear evidence from readily available sources of an innovative drug pipeline, named molecular targets, or human clinical-stage assets. Because the requested name "Xinjiang Tianli" more commonly maps to petrochemical businesses in Xinjiang, this match should be treated as tentative rather than exact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinjiang Tianli.